PRO-229 Ophthalmic Solution
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PRO-229 Ophthalmic Solution, covering 2025-03-04 to 2025-03-04. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study to Evaluate the Safety and Tolerability of PRO-229 Ophthalmic Solution Compared to Lagricel® Ofteno PF [Phase 1]